Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

PROPEL Study - A Study Comparing ATB200/AT2221 With Alglucosidase/Placebo in Adult Subjects With LOPD

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03729362
Recruitment Status : Completed
First Posted : November 2, 2018
Last Update Posted : February 15, 2021
Sponsor:
Information provided by (Responsible Party):
Amicus Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 15, 2021
Actual Study Completion Date : January 15, 2021